Status:
TERMINATED
Synthetic Metabolic and Genetic Networks for Medical Diagnosics
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
MICALIS
CBS
Conditions:
Prostate
Cancer
Eligibility:
MALE
18+ years
Brief Summary
This is a category 3 human study, prospective, comparative, in parallel groups. A comparative qualitative and quantitative analysis of several markers in 250 samples is proposed.
Detailed Description
The assumption is that researchers can engineer synthetic metabolic and genetic networks to expand the panel of molecules that are currently known to be detected by natural systems. The investigators ...
Eligibility Criteria
Inclusion
- Men aged over 18
- Informed, written consent of the patient for the biological collection
- Subject affiliated to a French social security scheme or beneficiary of such a scheme
- Patients specific inclusion criteria :
- \- Admitted to care prostate disease or suspicion of prostate cancer and with a positive or negative PSA blood result
- Controls specific inclusion criteria :
- \- Man free from all prostate or bladder pathologies
Exclusion
- Patient under legal protection
- Persons deprived of their liberty, protected adults or vulnerable persons
- Participants may withdraw their consent at any time and for any reason whatsoever without incurring any negative consequences without change in their usual care
- Controls specific non-inclusion criteria :
- Patient with current prostatic or urinary infection
- History of treatment for prostate cancer other than surveillance management
Key Trial Info
Start Date :
January 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2025
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04518072
Start Date
January 6 2021
End Date
June 6 2025
Last Update
June 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Montpellier, Hérault, France, 34000
2
Clinique Beau Soleil
Montpellier, France